Business · 18/12/2023Updated: 10/17/2026 · 1 min read
Hoffmann-La Roche, Inc., et al.; Withdrawal of Approval of Two New Drug Applications
Summary
The US Food and Drug Administration (FDA) is withdrawing the approval of two new drug applications from multiple applicants, following written notifications that the drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →
Related companies